Obstetric outcome following epidural analgesia with bupivacaine-adrenaline 0.25% or bupivacaine 0.125% with sufentanil--a prospective randomized controlled study in 1000 parturients

Acta Anaesthesiologica Scandinavica
C OlofssonL Irestedt

Abstract

Epidural analgesia (EDA) is the most efficient method for pain relief during labour, but there is still a debate as to whether it interferes with the normal process of delivery. Some authors argue that the incidence of instrumental deliveries, Caesarean section, malrotation and protracted labour is increased in parturients receiving EDA. 1000 parturients were prospectively randomized to receive EDA either with a high dose of local anaesthetic (0.25% bupivacaine with adrenaline = HD) or with a low dose (0.125% bupivacaine with sufentanil 10 micrograms = LD). The incidence of instrumental delivery and Caesarean section and the need for oxytocin was reduced in the LD compared to HD group. The delivery time was similar with HD and LD among primiparous, but decreased significantly among multiparous in the LD group. The incidence of malrotation was low in both groups. The quality of analgesia was equal during the first stage in the 2 groups, but was lower in the LD group during the second stage. More parturients in the LD group ambulated, but this did not affect the incidence of instrumental delivery. It is concluded that a lower dosage of bupivacaine combined with sufentanil in epidural analgesia significantly improves the obstetric...Continue Reading

References

Jan 1, 1979·Acta Obstetricia Et Gynecologica Scandinavica·R JouppilaA Hollmén
Jan 1, 1977·American Journal of Obstetrics and Gynecology·J C Schellenberg
Jan 1, 1976·Acta Obstetricia Et Gynecologica Scandinavica·N Raabe, P Belfrage
Nov 1, 1991·American Journal of Perinatology·J A ThorpV M Parisi
May 1, 1991·Anesthesiology·D H Chestnut
Sep 23, 1989·BMJ : British Medical Journal·F Reynolds
Sep 1, 1989·American Journal of Obstetrics and Gynecology·J A ThorpD A Johnston
Jan 1, 1989·European Journal of Obstetrics, Gynecology, and Reproductive Biology·T Philipsen, N H Jensen
May 1, 1987·Anesthesia and Analgesia·J C EisenachD M Dewan
Sep 4, 1986·The New England Journal of Medicine·R H de RegtR H Schwarz
Mar 1, 1984·Anaesthesia·P Walton, F Reynolds
Sep 11, 1982·British Medical Journal·B MorganP J Lewis
May 1, 1995·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M Finster
Nov 1, 1995·Obstetrics and Gynecology·S M RaminK J Leveno
Nov 1, 1993·Anesthesia and Analgesia·T W BreenN E Oriol
Oct 1, 1993·American Journal of Obstetrics and Gynecology·J A ThorpJ D Yeast
Oct 1, 1993·American Journal of Obstetrics and Gynecology·A M PeacemanM L Socol
Jan 1, 1992·International Journal of Obstetric Anesthesia·C J Howell, I Chalmers
Oct 1, 1994·International Journal of Obstetric Anesthesia·P RantaR Jouppila

❮ Previous
Next ❯

Citations

Jan 2, 2001·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·T W BreenL Dierenfield
Aug 9, 2013·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Pervez SultanBrendan Carvalho
Aug 24, 2004·International Journal of Obstetric Anesthesia·F ReynoldsN Smeeton
Dec 22, 2010·British Journal of Anaesthesia·C R Cambic, C A Wong
Jun 28, 2012·British Journal of Anaesthesia·J HermanidesP Lirk
Mar 27, 2001·MCN. the American Journal of Maternal Child Nursing·K R Simpson, G E Knox
Feb 9, 2010·Annals of African Medicine·S Fyneface-OganS E Anya
Jul 12, 2014·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Kai WangDun-Yi Qi
Sep 28, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S N LindebergU Hanson
May 23, 1998·Acta Anaesthesiologica Scandinavica·J A Thorp
Oct 17, 1998·Acta Anaesthesiologica Scandinavica·S Alahuhta, T I Ala-Kokko
Sep 24, 2004·BJOG : an International Journal of Obstetrics and Gynaecology·S W LindowI F Russell
Nov 22, 2002·European Journal of Anaesthesiology·O K RolfsengP C Borchgrevink
Oct 12, 2000·European Journal of Anaesthesiology·C Gomar, C Fernandez
Mar 6, 2010·International Journal of Obstetric Anesthesia·P Y DewandreJ F Brichant
May 16, 2002·American Journal of Obstetrics and Gynecology·Linda J MayberryAnindya De
Feb 29, 2000·American Journal of Obstetrics and Gynecology·L ImpeyM Robson
Jun 19, 2002·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Christine L RobertsBrian Peat
Oct 4, 2006·Current Opinion in Anaesthesiology·S A SchugH M Cardwell
Oct 3, 2006·Current Opinion in Anaesthesiology·A P Robinson, G Lyons
Sep 13, 2003·Acta Anaesthesiologica Scandinavica·S Ledin ErikssonC H Olofsson
Jan 25, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Christine L RobertsEmily Olive

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.